Michael Hamill
23Patents
10h-index
34Co-inventors
71Inventor score
Filing activity: Mar 15, 2013 → Jul 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9700071B2 | Nutritive fragments, proteins and methods | Human Necessities | 34 | Active |
| US9878004B2 | Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof | Physics | 19 | Active |
| US8822412B2 | Charged nutritive proteins and methods | Emerging Cross-Sectional Technologies | 19 | Active |
| US9605040B2 | Nutritive proteins and methods | Human Necessities | 15 | Active |
| US10471034B2 | Amino acid compositions and methods for the treatment of liver diseases | Human Necessities | 14 | Active |
| US10238617B2 | Amino acid compositions and methods for the treatment of liver diseases | Human Necessities | 14 | Active |
| US10201513B2 | Amino acid compositions and methods for the treatment of liver diseases | Human Necessities | 14 | Active |
| US9611298B2 | Charged nutritive proteins and methods | Emerging Cross-Sectional Technologies | 13 | Active |
| US9598474B2 | Nutritive fragments, proteins and methods | Human Necessities | 11 | Active |
| US10596136B2 | Compositions and methods for the treatment of fat infiltration in muscle | Human Necessities | 10 | Active |
| US10682325B2 | Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting | Human Necessities | 8 | Active |
| US10463711B2 | Nutritive polypeptides and formulations thereof, and methods of production and use thereof | Physics | 8 | Active |
| US10660870B2 | Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting | Human Necessities | 8 | Active |
| US11129804B2 | Amino acid compositions and methods for the treatment of liver diseases | Human Necessities | 2 | Active |
| US10973793B2 | Compositions and methods for the treatment of fat infiltration in muscle | Human Necessities | 2 | Active |
| US11602511B2 | Amino acid compositions and methods for the treatment of liver diseases | Human Necessities | 0 | Active |
| US11737999B2 | Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19 | Human Necessities | 0 | Active |
| US11357824B2 | Nutritive polypeptides and formulations thereof, and methods of production and use thereof | Physics | 0 | Active |
| US11571404B2 | Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting | Human Necessities | 0 | Active |
| US10450350B2 | Charged nutritive proteins and methods | Emerging Cross-Sectional Technologies | 0 | Active |
| US9944681B2 | Nutritive fragments, proteins and methods | Human Necessities | 0 | Active |
| US11096914B2 | Amino acid compositions and methods for the treatment of liver diseases | General | 0 | Revoked |
| US11833127B2 | Compositions and methods for the treatment of fat infiltration in muscle | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.